Cardiff Oncology Inc Asset Turnover Ratio (CRDF), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cardiff Oncology Inc   (NASDAQ: CRDF)
 

Cardiff Oncology Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Cardiff Oncology Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.01 in the third quarter (Sep 30 2026)

Within sector 68 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 2833 to 3791.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CRDF Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change 30.67 % 20.1 % -41.82 % -36.17 % 2.33 %
Y / Y Revenue Change 42.5 % -14.05 % -62.39 % 62 % -27.27 %
Asset Turnover Ratio (TTM) 0.01 0.01 0.01 0.01 0.01
CRDF's Total Ranking # 3791 # 2833 # 3490 # 0 #
Seq. Asset Change -8.38 % 84.99 % -20.54 % -2.97 % -15.79 %
Seq. Revenue Change 64.42 % 153.66 % -83.13 % 102.5 % -0.83 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 69
Healthcare Sector # 551
Overall Market # 3791

Asset Turnover Ratio Statistics
High Average Low
0.06 0.02 0
(Dec 31 2012)   (Sep 30 2021)




CRDF Company Profile • Back to CRDF Efficiency Comparisons • Compare CRDF Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Dbv Technologies S a   0.02 $ 3.844  Millions$ 234.675  Millions
Anteris Technologies Global Corp   0.01 $ 2.332  Millions$ 227.598  Millions
Crispr Therapeutics Ag  0.01 $ 25.172  Millions$ 2,549.561  Millions
Upstream Bio Inc   0.01 $ 2.870  Millions$ 299.747  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.